{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T05:49:41Z","timestamp":1741153781796,"version":"3.38.0"},"reference-count":22,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T00:00:00Z","timestamp":1741132800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Ophthal Inflamm Infect"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To present the demographic and clinical presentations of anterior scleritis among Iranian patients.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>This retrospective case-series at a tertiary center in Iran, identified and analyzed anterior scleritis cases admitted from 2008 to 2018. Extracted data included demographics, clinical features, background systemic diseases, utilized therapies, and follow-up data on visual outcomes, ocular complications, and recurrence rate. Patients with incomplete records were excluded from the analysis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Sixty-five patients (83 eyes) with anterior scleritis were included, with a female predilection (77%) and a mean age (\u00b1\u2009SD; range) of 44.8 (\u00b1\u200914.6; 11\u201381). Diffuse and necrotizing scleritis were the most and least common subtypes, respectively. Bilateral involvement (28% at baseline, 44.6% eventually) and concurrent keratitis (10.7%) or uveitis (16.9%) were documented in some cases. Most cases were idiopathic (61.5%). Scleritis was the initial manifestation of autoimmune diseases in six patients. In addition to oral and\/or intravenous corticosteroid therapy, most of our patients (70.7%) were treated with immunosuppressive regimens. No inter-subtype difference was noted in recurrence rate and time to treatment cessation. Necrotizing subtype was associated with worse visual outcomes and more frequent ocular complications.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Despite limitations in data collection and follow-up, our findings contribute valuable insights into the clinical characteristics and management of scleritis in a group of Iranian patients for the first time.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s12348-025-00473-x","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T03:38:46Z","timestamp":1741145926000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Scleritis in Iran"],"prefix":"10.1186","volume":"15","author":[{"given":"Sahba","family":"Fekri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reza","family":"Esmaili Fallah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoud","family":"Soheilian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1459-6752","authenticated-orcid":false,"given":"Seyed-Hossein","family":"Abtahi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1808-0443","authenticated-orcid":false,"given":"Hosein","family":"Nouri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,5]]},"reference":[{"issue":"4","key":"473_CR1","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.survophthal.2005.04.001","volume":"50","author":"N Okhravi","year":"2005","unstructured":"Okhravi N, Odufuwa B, McCluskey P, Lightman S (2005) Scleritis. Surv Ophthalmol 50(4):351\u2013363.","journal-title":"Surv Ophthalmol"},{"issue":"7","key":"473_CR2","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1002\/art.41709","volume":"73","author":"T Braithwaite","year":"2021","unstructured":"Braithwaite T, Adderley NJ, Subramanian A, Galloway J, Kempen JH, Gokhale K et al (2021) Epidemiology of Scleritis in the United Kingdom From 1997 to 2018: Population-Based Analysis of 11 Million Patients and Association Between Scleritis and Infectious and Immune-Mediated Inflammatory Disease. Arthritis Rheumatol Hoboken NJ 73(7):1267\u20131276","journal-title":"Arthritis Rheumatol Hoboken NJ"},{"issue":"3","key":"473_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.xops.2022.100178","volume":"2","author":"KR Armbrust","year":"2022","unstructured":"Armbrust KR, Kopplin LJ (2022) Characteristics and Outcomes of Patients with Scleritis in the IRIS\u00ae Registry (Intelligent Research in Sight) Database. Ophthalmol Sci 2(3):100178","journal-title":"Ophthalmol Sci"},{"issue":"4","key":"473_CR4","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1016\/j.ajo.2013.05.026","volume":"156","author":"G Homayounfar","year":"2013","unstructured":"Homayounfar G, Nardone N, Borkar DS, Tham VM, Porco TC, Enanoria WTA et al (2013) Incidence of Scleritis and Episcleritis: Results From the Pacific Ocular Inflammation Study. Am J Ophthalmol 156(4):752-758.e3","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"473_CR5","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.1097\/ICO.0b013e3182a407c3","volume":"32","author":"G Honik","year":"2013","unstructured":"Honik G, Wong IG, Gritz DC (2013) Incidence and prevalence of episcleritis and scleritis in Northern California. Cornea 32(12):1562\u20131566","journal-title":"Cornea"},{"issue":"8","key":"473_CR6","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1586\/1744666X.2016.1171713","volume":"12","author":"M Oray","year":"2016","unstructured":"Oray M, Meese H, Foster CS (2016) Diagnosis and management of non-infectious immune-mediated scleritis: current status and future prospects. Expert Rev Clin Immunol 12(8):827\u2013837","journal-title":"Expert Rev Clin Immunol"},{"issue":"3","key":"473_CR7","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1136\/bjo.60.3.163","volume":"60","author":"PG Watson","year":"1976","unstructured":"Watson PG, Hayreh SS (1976) Scleritis and episcleritis. Br J Ophthalmol 60(3):163\u2013191","journal-title":"Br J Ophthalmol"},{"issue":"4","key":"473_CR8","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1007\/s11926-020-0885-y","volume":"22","author":"A Nevares","year":"2020","unstructured":"Nevares A, Raut R, Libman B, Hajj-Ali R (2020) Noninfectious Autoimmune Scleritis: Recognition, Systemic Associations, and Therapy. Curr Rheumatol Rep 22(4):11","journal-title":"Curr Rheumatol Rep"},{"issue":"1","key":"473_CR9","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1097\/ICO.0b013e3181ac9fad","volume":"29","author":"L Erkanli","year":"2010","unstructured":"Erkanli L, Akova YA, Guney-Tefekli E, Tugal-Tutkun I (2010) Clinical features, prognosis, and treatment results of patients with scleritis from 2 tertiary eye care centers in Turkey. Cornea 29(1):26\u201333","journal-title":"Cornea"},{"issue":"6","key":"473_CR10","first-page":"1215","volume":"8","author":"M Al Barqi","year":"2015","unstructured":"Al Barqi M, Behrens A, Alfawaz AM (2015) Clinical features and visual outcomes of scleritis patients presented to tertiary care eye centers in Saudi Arabia. Int J Ophthalmol 8(6):1215\u20131219","journal-title":"Int J Ophthalmol"},{"key":"473_CR11","doi-asserted-by":"crossref","unstructured":"Abd El Latif E, Seleet MM, El Hennawi H, Abdulbadiea Rashed M, Elbarbary H, Sabry K, et al. Pattern of Scleritis in an Egyptian Cohort. Ocul Immunol Inflamm. 2019;27(6):890\u20136","DOI":"10.1080\/09273948.2018.1544372"},{"issue":"2","key":"473_CR12","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1016\/j.ophtha.2012.08.005","volume":"120","author":"WG Wieringa","year":"2013","unstructured":"Wieringa WG, Wieringa JE, Ten Dam-van Loon NH, Los LI (2013) Visual Outcome, Treatment Results, and Prognostic Factors in Patients with Scleritis. Ophthalmology 120(2):379\u2013386","journal-title":"Ophthalmology"},{"issue":"5","key":"473_CR13","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.3390\/jcm12051969","volume":"12","author":"C Arruza","year":"2023","unstructured":"Arruza C, Requejo Figueroa GA, Col\u00f3n J, Ramirez Marquez E, Puebla G, Ortega D et al (2023) Systemic Disease Associations in a Cohort of Hispanic Patients with Scleritis. J Clin Med 12(5):1969","journal-title":"J Clin Med"},{"key":"473_CR14","doi-asserted-by":"crossref","unstructured":"Sainz De La Maza M, Molina N, Gonzalez-Gonzalez LA, Doctor PP, Tauber J, Foster CS. Clinical Characteristics of a Large Cohort of Patients with Scleritis and Episcleritis. Ophthalmology. 2012;119(1):43\u201350","DOI":"10.1016\/j.ophtha.2011.07.013"},{"issue":"3","key":"473_CR15","doi-asserted-by":"publisher","first-page":"293","DOI":"10.5301\/ejo.5000394","volume":"24","author":"L Berchicci","year":"2014","unstructured":"Berchicci L, Miserocchi E, Di Nicola M, La Spina C, Bandello F, Modorati G (2014) Clinical Features of Patients with Episcleritis and Scleritis in an Italian Tertiary Care Referral Center. Eur J Ophthalmol 24(3):293\u2013298","journal-title":"Eur J Ophthalmol"},{"issue":"11","key":"473_CR16","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1136\/bjo.2009.171744","volume":"94","author":"H Keino","year":"2010","unstructured":"Keino H, Watanabe T, Taki W, Nakashima C, Okada AA (2010) Clinical features and visual outcomes of Japanese patients with scleritis. Br J Ophthalmol 94(11):1459\u20131463","journal-title":"Br J Ophthalmol"},{"issue":"1","key":"473_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/j.tjo.2014.10.004","volume":"5","author":"YW Chen","year":"2015","unstructured":"Chen YW, Poon YC, Yu HJ, Kuo MT, Fan PC (2015) Experience of scleritis and episcleritis at a tertiary center in Southern Taiwan. Taiwan J Ophthalmol 5(1):19\u201322","journal-title":"Taiwan J Ophthalmol"},{"issue":"1","key":"473_CR18","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s12348-017-0124-5","volume":"7","author":"MA Bin Ismail","year":"2017","unstructured":"Bin Ismail MA, Lim RHF, Fang HM, Wong EPY, Ling HS, Lim WK et al (2017) Ocular Autoimmune Systemic Inflammatory Infectious Study (OASIS)\u2014report 4: analysis and outcome of scleritis in an East Asian population. J Ophthalmic Inflamm Infect 7(1):6","journal-title":"J Ophthalmic Inflamm Infect"},{"issue":"6","key":"473_CR19","doi-asserted-by":"publisher","first-page":"920","DOI":"10.1080\/09273948.2018.1484496","volume":"27","author":"J Lane","year":"2019","unstructured":"Lane J, Nyugen E, Morrison J, Lim L, Stawell R, Hodgson L et al (2019) Clinical Features of Scleritis Across the Asia-Pacific Region. Ocul Immunol Inflamm 27(6):920\u2013926","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"473_CR20","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1080\/09273948.2020.1716026","volume":"29","author":"Z Rahman","year":"2021","unstructured":"Rahman Z, Jafarullah O, Huq N, Hasan K, Magesan K, Dutta MP (2021) Clinical Profile of Patients with Scleritis in Bangladesh. Ocul Immunol Inflamm 29(6):1102\u20131105","journal-title":"Ocul Immunol Inflamm"},{"issue":"6","key":"473_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.3341\/kjo.2010.24.6.331","volume":"24","author":"SJ Ahn","year":"2010","unstructured":"Ahn SJ, Oh JY, Kim MK, Lee JH, Wee WR (2010) Clinical features, predisposing factors, and treatment outcomes of scleritis in the Korean population. Korean J Ophthalmol KJO 24(6):331\u2013335","journal-title":"Korean J Ophthalmol KJO"},{"issue":"1","key":"473_CR22","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s12886-020-01769-3","volume":"21","author":"MK Berkenstock","year":"2021","unstructured":"Berkenstock MK, Carey AR (2021) Health system wide \u201cbig data\u201d analysis of rheumatologic conditions and scleritis. BMC Ophthalmol 21(1):14","journal-title":"BMC Ophthalmol"}],"container-title":["Journal of Ophthalmic Inflammation and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-025-00473-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12348-025-00473-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12348-025-00473-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T03:38:50Z","timestamp":1741145930000},"score":1,"resource":{"primary":{"URL":"https:\/\/joii-journal.springeropen.com\/articles\/10.1186\/s12348-025-00473-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,5]]},"references-count":22,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["473"],"URL":"https:\/\/doi.org\/10.1186\/s12348-025-00473-x","relation":{},"ISSN":["1869-5760"],"issn-type":[{"value":"1869-5760","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,5]]},"assertion":[{"value":"18 August 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethics committee of Shahid Beheshti University of Medical Sciences approved the protocol of this study (code: IR.SBMU.MSP.REC.1398.174).\u00a0A waiver for acquiring consent to participate\u00a0was granted due to the retrospective nature of the study, provided that individuals\u2019 anonymity was observed at all stages of the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable, because\u00a0no data that could endanger participants\u2019 identity was used.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"17"}}